Table 1.
Experimental | Control | Pilot | |
---|---|---|---|
Demographic | |||
Gender, m/f | 9/3 | 8/4 | 6/3 |
Age, years | 55±12 | 61±10 | 53±14 |
Duration post-stroke, days | 108±57 | 89±40 | 118±59 |
Type, hemorrhagic/ischemic | 4/6 | 1/11 | 3/6 |
Lesion side, right/left | 7/5 | 9/3 | 6/3 |
Assistive Device at BSL, y/n | 10/2 | 9/3 | 9/0 |
Training Outcomes | |||
Sessions, n | 34±9.7 | 34±8.2 | 37±7.6 |
Steps/session | 2641±727 | 1043±465 | 2993±637 |
Average peak HR reserve (%) | 73±8.5 | 57±8.6 | 73±12 |
Adverse Events | |||
Falls without injury (n) | 6 | 8 | 2 |
Hypertension/angina (n) | 1 | 0 | 3 |
Seizure (n) | 0 | 1 | 0 |
Joint/back pain (n) | 3 | 1 | 2 |
Skin breakdown (n) | 3 | 3 | 0 |
Unable to determine stroke type from medical records for 2 experimental subjects; P Value represents significance level of independent t-test between experimental and control training outcomes